Abstracts
sis and classified according to ASRM. Patients were treated with standard ovulation induction protocols and underwent IVF-ET according to previously published guidelines. Demographics, stimulation protocols and results, retrieval and transfer data, and pregnancy outcomes were analyzed. Clinical pregnancy was defined as the presence of a gestational sac. An ongoing pregnancy was defined as a pregnancy continuing beyond the 20th week of gestation. Analysis of variance, Chi square, and student's t-test were utilized when appropriate. P < 0.05 was considered significant.
Results: 1196 (84.4%) of the 1417 initiated cycles went to retrieval. 1105/1196 (92.3%) underwent an embryo transfer. An overall clinical pregnancy rate/transfer of 44.7% (495/1105) and an overall ongoing pregnancy rate/transfer of 37.1% were noted. In analyzing all cycles that went to transfer, the stage of disease had no significant effect on peak estradiol levels, number of mature oocytes or embryos transferred, or pregnancy outcome. As expected, age was found to have a significant effect on IVF-ET outcome. Patients under 40 years old had a significantly higher clinical pregnancy rate/transfer than those 40 and over (48.4% vs. 31.8%; p < 0.001). To remove the effect of individual patients with multiple failed cycles and perhaps other unknown contributing causes of infertility, we next analyzed the first cycle of each patient with endometriosis. Once again, the stage of disease had no significant effect on peak estradiol levels, number of mature oocytes or embryos transferred, or pregnancy outcome. In analyzing the population by stimulation protocol, patients with lupreolide acetate down-regulated cycles were found to be younger, stimulate better, and had significantly higher clinical pregnancy rates (48.9% vs. 27.2%; P < 0.001). Given that patients with lupreolide acetate down-regulated cycles were found to have better outcomes, we than analyzed these patients to detect if stage of disease had any effect on IVF-ET outcome. In these patients, lower stages of endometriosis were associated with older women that stimulated better, had more oocytes retrieved, and had more embryos fertilized. Despite this, no differences in the ultimate number of embryos transferred or, more importantly, pregnancy outcomes were detected. We then analyzed the 741 cycles of patients with pure endometriosis as the only cause of infertility. In these patients, the stage of disease had no significant effect on peak estradiol levels, number of mature oocytes, number of embryos transferred, or preg-ABSTRACTS nancy outcome. We then attempted to analyze for the presence of endometriosis and its affect on outcome after IVF-ET. Given that most of the variability in pregnancy outcomes after IVF-ET is related to age and that until the age of 35 we have implantation rates that are constant, we then analyzed all ICSI cycles (1995) (1996) Early pregnancy factor (EPF), a pregnancy associated immunosuppressive molecule, was detected in the pregnant serum of a mouse within 6 hours of mating, and its activity was also detected in the The need to study genital herpes virus (HSV) and cytomegalovirus (CMV) is mandated by a continuing increase of the number of patients affected by these disorders, the high rate of perinatal losses and the birth of babies with severe brain damage. We have studied 182 pregnant women with HSV and CMV; 167 patients had initial manifestation of infection in the course of pregnancy. Herpes infection which occurred after the 32nd week of pregnancy has affected 20% of the newborns, while infection occurring shortly before labor has infected 40% of the newborns. All patients have been diagnosed using immunological methods. Analysis of the subpopulations of peripheral blood lymphocytes in pregnant women with genital herpes revealed a reduction in the levels of T-lymphocytes (CD3+), an increase in the levels of T-suppressor cells (CD8+) and B-cells (CD19+) and a significant reduction in the level ofT-helper cells (CD4+ 
